Literature DB >> 26694743

Obesity and hyperglycemia lead to impaired post-ischemic recovery after permanent ischemia in mice.

Jatin Tulsulkar1, Shadia E Nada1, Brandon D Slotterbeck1, Marcia F McInerney1,2,3, Zahoor A Shah1,2.   

Abstract

OBJECTIVE: Obesity-induced diabetes has increased over the years and has become one of the risk factors for stroke. We investigated the influence of diet-induced obesity and hyperglycemia on permanent distal middle cerebral artery occlusion (pMCAO)-induced ischemic stroke in mice.
METHODS: Male C57/Bl6 mice were treated with a high-fat/high-carbohydrate diet [HFCD/obese and hyperglycemia (O/H)] or a normal diet (control) for 3.5 months, subjected to pMCAO, and sacrificed after 7 days.
RESULTS: Infarct volume analysis showed no differences between the O/H and control group, whereas neurological deficits were significantly higher in the O/H group compared to the control group. Sirtuin (Sirt1) was overexpressed and NADPH oxidase was reduced in the O/H group. O/H mice had significantly lower expression of Wnt and glycogen synthase kinase 3 α and β, a key component in the Wnt signaling pathway. Translocation of apoptosis inducing factor (AIF) to the nucleus was observed in both the O/H and control groups, but O/H mice showed a higher expression of AIF in the nucleus.
CONCLUSIONS: These data suggest that impaired Wnt signaling and active apoptosis result in reduced post-stroke recovery in obese and hyperglycemic mice.
© 2015 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26694743      PMCID: PMC4731242          DOI: 10.1002/oby.21388

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

1.  Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death.

Authors:  R S Morrison; H J Wenzel; Y Kinoshita; C A Robbins; L A Donehower; P A Schwartzkroin
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

2.  White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke.

Authors:  Jieli Chen; Xu Cui; Alex Zacharek; Yisheng Cui; Cynthia Roberts; Michael Chopp
Journal:  Stroke       Date:  2010-12-30       Impact factor: 7.914

3.  Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761®) after permanent ischemic stroke in mice.

Authors:  Shadia E Nada; Jatin Tulsulkar; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2013-10-24       Impact factor: 5.590

4.  Trends in stroke hospitalizations and associated risk factors among children and young adults, 1995-2008.

Authors:  Mary G George; Xin Tong; Elena V Kuklina; Darwin R Labarthe
Journal:  Ann Neurol       Date:  2011-09-02       Impact factor: 10.422

5.  Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.

Authors:  Jaroslaw Jozwiak; Katarzyna Kotulska; Wieslawa Grajkowska; Sergiusz Jozwiak; Wojciech Zalewski; Monika Oldak; Magdalena Lojek; Kamila Rainko; Radosław Maksym; Maciej Lazarczyk; Piotr Skopinski; Pawel Wlodarski
Journal:  Brain Dev       Date:  2006-10-27       Impact factor: 1.961

6.  Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Jinling Hou; Kenneth Maiese
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

7.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

8.  Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation.

Authors:  Chie Kanei-Ishii; Teruaki Nomura; Jun Tanikawa; Emi Ichikawa-Iwata; Shunsuke Ishii
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

9.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

10.  Wnt signaling in the regulation of adult hippocampal neurogenesis.

Authors:  Lorena Varela-Nallar; Nibaldo C Inestrosa
Journal:  Front Cell Neurosci       Date:  2013-06-26       Impact factor: 5.505

View more
  12 in total

1.  Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke.

Authors:  Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-12       Impact factor: 6.200

Review 2.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

Review 3.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 4.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

Review 5.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

6.  Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

Authors:  Kenneth Maiese
Journal:  Int Rev Neurobiol       Date:  2020-08-11       Impact factor: 3.230

Review 7.  New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

Authors:  Kenneth Maiese
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

Review 8.  Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

Review 9.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

10.  Type-I diabetes aggravates post-hemorrhagic stroke cognitive impairment by augmenting oxidative stress and neuroinflammation in mice.

Authors:  Ghaith A Bahader; Kevin M Nash; Daniyah A Almarghalani; Qasim Alhadidi; Marcia F McInerney; Zahoor A Shah
Journal:  Neurochem Int       Date:  2021-08-01       Impact factor: 4.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.